medical device investing Accuray to Report First Quarter Fiscal 2027 Financial Results on November 4, 2026
medical device investing Accuray Announces Stockholder Approval of Key Financing-Related Proposals and Appointment of New Independent Director
medical device investing Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® Platform
medical device investing Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities
medical device investing Accuray Advances Strategic Priorities Through Key Executive Leadership Appointments
medical device investing Accuray to Report Fourth Quarter Fiscal 2026 Financial Results on August 19, 2026
medical device investing Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer
medical device investing Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026
medical device investing Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer
medical device investing Accuray to Report Second Quarter Fiscal 2026 Financial Results on February 4, 2026
